Featured Post
NEWS FROM SWEDEN: First delivery of extemporaneous medicinal products manufactured using 3D technology
First delivery of extemporaneous medicinal products manufactured using 3D technology
Apotek Produktion och Laboratorier AB (APL), one of the largest manufacturers of compounded medicines and a leading Contract Development and Manufacturing Organization (CDMO) in Sweden, announces its first delivery of a compounded medicine produced by 3D-printing technology. APL applies 3D-printing technology within the concept ExtempoPrint.
Evaluation of CurifyLabs Technology in the European Journal of Pharmaceutical Sciences
Transforming Pediatric Care with CurifyLabs' Automated Compounding System, European Journal of Pharmaceutical Sciences
Women's Health and the Transformative Role of Personalized Medicine
Women's health CurifyLabs personalized medicines
Developing Technologies that Benefit All Payors in Healthcare: A Path to a More Efficient and Affordable System
Costs and return on investment CurifyLabs
.jpeg)
Läkartidningen: 3D-Printed Medications to Fill Gaps in Swedish Market
Läkartidningen on 3D printing of medicines
APL and CurifyLabs partnership to support critically ill patients with 3D printing medicine technology
CurifyLabs to partner with APL
-3.png)
ROI Video: How Much Time Can a Pharmacist Save in Compounding Using the CurifyLabs Pharma Kit?
ROI on CurifyLabs technology - manual compounding VS automated compounding with the Pharma Kit
Personalized Medicine from a Patient Point of View
Personalized medicine from a patient point of view